Downloads

Downloads

Current Presentations

Date Title File
Nov 18, 2024
Immatics Corporate Presentation November 2024
Nov 18, 2024
TCR Bispecific Molecule TCER® IMA402 Targeting PRAME - Phase 1 Dose Escalation Clinical Data Update
Nov 08, 2024
Combination of a TCR-engineered Autologous PRAME-targeting T Cell Therapy with a PRAME-encoding mRNA for the Treatment of Solid Tumors
Nov 08, 2024
ACTengine® IMA203 TCR-T Targeting PRAME Shows Deep and Durable Anti-Tumor Activity in Heavily Pretreated Solid Cancer Patients
Nov 08, 2024
Enhanced Pharmacology Data of Next-generation IMA203CD8 TCR-T Monotherapy Targeting PRAME
Oct 10, 2024
ACTengine® IMA203 TCR-T Targeting PRAME in PD1 Refractory Metastatic Melanoma - Phase 1b Dose Expansion Clinical Data Update
Sep 16, 2024
TCER® IMA401 Targeting MAGEA4/8 - Phase 1 Dose Escalation Clinical Data Update
Nov 08, 2023
ACTengine® IMA203 Clinical Data Update at Society for Melanoma Research Congress, November 2023
Nov 08, 2023
ACTengine® IMA203 & IMA203CD8 TCR-T Monotherapy Targeting PRAME - Phase 1 Interim Data Update
Nov 10, 2022
Next-generation TCER® Format Presentation at SITC Annual Meeting, November 2022

Archive

Date Title File
Nov 10, 2020
Immatics ACTolog® IMA101 Phase-1-Data at the 35th Annual SITC conference

Media Materials